Energy balance and cancer: The role of sex hormones

Proceedings of the Nutrition Society

Volumn 60, Issue 1, 2001, Pages 81-89

  Key, T J ^a   Allen, N E ^a   Verkasalo, P K ^a   Banks, E ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cancer; Energy balance; Obesity; Sex hormones

Indexed keywords

ANDROGEN; ESTRADIOL; ESTROGEN; SEX HORMONE; SEX HORMONE BINDING GLOBULIN;

BODY MASS; BREAST CANCER; CANCER; CANCER RISK; CARCINOGENESIS; CONFERENCE PAPER; ENDOMETRIUM CANCER; ENERGY BALANCE; ENERGY TRANSFER; HORMONAL REGULATION; HUMAN; METABOLISM; NEGATIVE FEEDBACK; NUTRIENT; OBESITY; OVARY CANCER; OVULATION;

EID: 0035123903     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS200068     Document Type: Conference Paper

References (86)

1. Parity, age at first childbirth, and risk of ovarian cancer
2. Energy balance, body size, and cancer
3. Height, early energy intake, and cancer: Evidence mounts for the relation of energy intake to adult malignancies
4. Are cell number and cell proliferation risk factors for cancer?
5. Hormones and diet: Low insulin-like growth factor-1 but normal bioavailable androgens in vegan men
6. Cell turnover in the 'resting' human breast: Influence of parity, contraceptive pill, age and laterality
7. Body size and prostate cancer: A 20-year follow-up study among 135006 Swedish construction workers
8. The epidemiology of epithelial ovarian cancer: A review
9. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women
10. Risk factors for ovarian cancer: A case control study
11. 'Incessant Ovulation' and ovarian cancer
12. Control of prostate growth
13. Cell proliferation in carcinogenesis
14. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer
15. Transport of steroid hormones: Binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma
16. Endogenous sex hormones and prostate cancer: A quantitative review of prospective studies
17. Association of obesity and ovarian cancer in a case-control study
18. Incessant ovulation - A factor in ovarian neoplasia?
19. The relation of smoking, age, relative weight and dietary intake to serum adrenal steroids, sex hormones and sex hormone binding globulin in middle-aged men
20. Association of incident carcinoma of the endometrium with body weight and fat distribution in older women: Early findings of the Iowa Women's Health Study
21. Pooled analysis of 3 European case-control studies of ovarian cancer: II Age at menarche and at menopause
22. Risk factors for epithelial ovarian cancer in Italy
23. Childhood energy intake and adult mortality from cancer: The Boyd Orr cohort study
24. The role of nutrition and insulin in the regulation of sex hormone binding globulin
25. Analysis of dietary fat, calories, body weight, and the development of mammary tumors in rats and mice: A review
26. Anthropometric predictors of breast cancer incidence and survival in a multi-ethnic cohort of female residents of Hawaii, United States
27. Prospective study of sex hormone levels and risk of prostate cancer
28. Energy balance and cancers
29. Height, body weight, and risk of prostate cancer
30. Sex steroid, gonadotropin, cortisol, and prolactin levels in healthy, massively obese women: Correlation with abdominal fat cell size and effect of weight reduction
31. Leg length and risk of cancer in the Boyd Orr cohort
32. A case-control study of epithelial ovarian cancer
33. Nutritional and socio-economic factors in relation to prostate cancer mortality: A cross-national study
34. Serum gonadotropins and steroid hormones and the development of ovarian cancer
35. The epidemiology of endometrial cancer in young women
36. Lactose and galactose intake and metabolism in relation to the risk of epithelial ovarian cancer
37. An epidemiologic study of epithelial carcinoma of the ovary
38. Dual effects of weight and weight gain on breast cancer risk
39. Tubal sterilisation, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer
40. Origin of serum estradiol in postmenopausal women
41. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: Its central role in explaining and predicting endometrial cancer risk
42. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer
43. Risk factors of ovarian cancer of epithelial origin: A case-control study
44. Risk factors for endometrial cancer at different ages
45. Variations in mortality by weight among 750,000 men and women
46. Is estradiol a genotoxic mutagenic carcinogen?
47. Anthropometry and prostate cancer risk: A prospective study of 22,248 Norwegian men
48. The effect of retarded growth upon the length of life span and upon the ultimate body size
49. Dietary and physical determinants of menarche
50. Nutrition, body size, and breast cancer
51. Physical activity, waist-to-hip ratio, and other risk factors for ovarian cancer: A follow-up study of older women
52. The development of prostate adenocarcinoma in Nb rats following prolonged sex hormone administration
53. Prostate cancer: A current perspective
54. Fat, calories, and mammary carcinogenesis: Net energy effects
55. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal-weight and obese men
56. Combined effects of body size, parity, and menstrual events on breast cancer incidence in seven countries
57. Determinants of age at menarche as early life predictors of breast cancer risk
58. Estrogen-progestin replacement therapy and endometrial cancer
59. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk
60. Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer
61. Case-control study of endogenous steroid hormones and endometrial cancer
62. Increased cell division as a cause of human cancer
63. Reproductive and other factors and risk of epithelial ovarian cancer: An Australian case-control study
64. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone
65. Estrogen replacement therapy and fatal ovarian cancer
66. Body mass and prostatic cancer: A prospective study
67. Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: The inadequate luteal phase
68. Population-based case-control study of ovarian cancer in Shanghai
69. Role of extraglandular estrogen in human endocrinology
70. Nutrient intake and ovarian cancer
71. The initiation and growth of tumors
72. Oestradiol and sex hormone-binding globulin in premenopausal and postmenopausal meat-eaters, vegetarians and vegans
73. Obesity, fat intake, energy balance, exercise and cancer risk: A review
74. Body size and risk of breast cancer
75. Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570,000 women in Norway
76. A meta-analysis of body mass index and risk of premenopausal breast cancer
77. Circulating levels of sex hormones and their relation to risk factors for breast cancer: A cross-sectional study in 1092 pre- and postmenopausal women
78. Attenuated luteinising hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men
79. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males
80. Risk of endometrial cancer following estrogen replacement with and without progestins
81. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden)
82. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women
83. Serum androgens and sex hormone-binding globulin in relation to lifestyle factors in older African-American, white and Asian men in the United States and Canada
84. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use
85. Endocrine comparison of obese menstruating and amenorrheic women